Home > Insider Trading > Filing (0000874015-15-000007)

Filing Details

Accession Number:: 0000874015-15-000007
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-01-05 20:03:45
Reporting Period:: 2015-01-01

Filing Date:: 2015-01-05
Accepted Time:: 2015-01-05 20:03:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
874015	Isis Pharmaceuticals Inc	ISIS	Pharmaceutical Preparations (2834)	330336973

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1564926	R. Patrick O'neil	C/O Isis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad CA 92010	Svp, Legal & General Counsel	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-01	329	$30.05	4,082	No	5	J	Direct
Common Stock	Acquisiton	2015-01-02	1,217	$10.82	5,299	No	4	M	Direct
Common Stock	Disposition	2015-01-02	1,217	$62.12	4,082	No	4	S	Direct
Common Stock	Acquisiton	2015-01-02	283	$7.25	4,365	No	4	M	Direct
Common Stock	Disposition	2015-01-02	283	$62.12	4,082	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	5	J	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Acquisiton	2015-01-02	31,457	$0.00	31,457	$61.57
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-01-02	1,217	$0.00	1,217	$10.82
Common Stock	Employee Stock Option (right to buy)	Disposition	2015-01-02	283	$0.00	283	$7.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
31,457	2016-01-02	2022-01-01	No	4	A	Direct
13,353	2014-01-02	2020-01-01	No	4	M	Direct
9,750	2013-01-03	2019-01-02	No	4	M	Direct

Footnotes

Reporting 329 shares acquired under the Isis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on January 1, 2015. These 329 shares may not be sold until July 2, 2015.
Acquired as a result of exercising a stock option pursuant to a Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 1/2/2014.
Grant of 1/2/2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2016. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 7,865 shares per year. The option was exercisable as to 0 on 1/2/2015.
Grant of 1/2/2013 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/2/2014. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 3,925 shares per year. Following this transaction, the option was exercisable as to 5,503 on 1/2/2015.
Grant of 1/3/2012 to reporting person of stock options under the Isis Pharmacueticals, Inc. 1989 Stock Option Plan. 25% of the shares subject to the option vested and became exercisable on 1/3/2013. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 4,875 shares per year. Following this transaction, the option was exercisable as to 4,468 on 1/2/2015.